(Q40813351)

24 September 2017

title

Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes (English)

1 reference

24 September 2017

Willard-Gallo KE

1

1 reference

24 September 2017

Furtado M

series ordinal

2

1 reference

24 September 2017

Burny A

series ordinal

3

1 reference

24 September 2017

Wolinsky SM

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

European Journal of Immunology

24 September 2017

published in

1 reference

24 September 2017

volume

31

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

969-979

1 reference

Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibody

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Assembly of the TCR/CD3 complex: CD3 epsilon/delta and CD3 epsilon/gamma dimers associate indistinctly with both TCR alpha and TCR beta chains. Evidence for a double TCR heterodimer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Modulation of CD3-gamma gene expression after HIV type 1 infection of the WE17/10 T cell line is progressive and occurs in concert with decreased production of viral p24 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

The Nef protein of HIV-1 associates with rafts and primes T cells for activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Nef and the Nef-associated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

The HIV nef protein associates with protein kinase C theta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

The T-cell receptor zeta chain contains two homologous domains with which simian immunodeficiency virus Nef interacts and mediates down-modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Serine phosphorylation-independent downregulation of cell-surface CD4 by nef

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

Quantification of human immunodeficiency virus type 1 tat mRNA as a marker for assessing the efficacy of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

From TCR Engagement to T Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200104%2931%3A4%3C969%3A%3AAID-IMMU969%3E3.0.CO%3B2-2

10.1002/1521-4141(200104)31:4<969::AID-IMMU969>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference